Research and Markets: Rabies Virus Vaccines, Antibodies and Immune Globulins Competitor Analysis

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/sqppsm/competitor) has announced the addition of the "Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins" report to their offering.

The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment of Rabies virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed and active projects in research and development of therapeutic antibodies, immune globulins and vaccines for prevention and treatment of Rabies virus infections. In addition, the report lists company-specific R&D pipelines of Rabies virus vaccines, antibodies and immune globulins.

Competitor projects are listed in a tabular format providing information on:

  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Company
  • Product Category
  • Indication
  • R&D Stage

Key Topics Covered:

1. Equine Rabies Virus Immune Globulins (ERIG)

2. Human Rabies Virus Immune Globulins (HRIG)

3. Recombinant Rabies Antibodies

4. Rabies Virus Vaccines

Companies Mentioned

  • Bharat Biotech
  • Bharat Serums & Vaccines
  • Bio Products Laboratory (BPL)
  • Cadila Pharmaceuticals
  • Celltrion
  • China Biological Products (CBP)
  • China National Biotec Group (CNBG)
  • CPL Biologicals (JV of Cadila Pharmaceuticals & Novavax)
  • CSL (CSL Behring / CSL Biotherapies)
  • Duraent Biologicals
  • Grifols
  • Haffkine Bio-Pharmaceutical Corp. (HBPC)
  • Humabs Biomed
  • Indian Immunologicals
  • Johnson & Johnson (Crucell)
  • Kamada
  • Liaoning Cheng Da Biotechnology
  • Massachusetts Biologics Laboratories (MBL)
  • Mitsubishi Tanabe Pharma (Medicago)
  • Molecular Targeting Technologies (MTT)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • North China Pharmaceutical Group (NCPC)
  • Novartis
  • PaxVax
  • Sanofi Pasteur
  • Serum Institute of India
  • Sichuan Yuanda Shuyang Pharmaceutical
  • The Chemo-Sero Therapeutic Research Institute (Kaketsuken)
  • Thomas Jefferson University
  • Wuhan Institute of Biological Products (WIBP)

For more information visit http://www.researchandmarkets.com/research/sqppsm/competitor

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Immune Disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Immune Disorders